Contribute to koninti-nikhitha/recursion-python-problems development by creating an account on GitHub.

AI drug discovery is not a new phenomenon - but it is evolving at an almost dizzying pace - and Recursion is one of the earliest innovators in the space.

Recursion Pharmaceuticals dropped for a third straight day on Wednesday, slashing 6.29 percent to close at $4.77 apiece after investors mimicked the recent selling of three company executives.

According to data compiled by S&P Global Market Intelligence, Recursion Pharmaceuticals (NASDAQ: RXRX) stock was shedding more than 17% of its value week-to-date as of Thursday night.

Recursion will also receive an additional $30 million upfront payment from Bayer to develop new treatments for chronic scar tissue, or fibrotic, diseases of the lung, kidneys and heart.

The Hundred knockout permutations: Who needs what to qualify for final stages of men's and women's seasons? Southern Brave have secured spot in women's final; Oval Invincibles have confirmed their ...

Find annual and quearterly earnings data for Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) including earnings per share, earnings forecasts at Nasdaq.com.

Explore RXRX's upcoming H2'25 trial updates for REC-4881 in familial adenomatous polyposis and REC-617.